CathLab Shock Score (CardShock-based) Calculator

Clinical calculation support · Verify results before clinical use

CardShock risk assessment

Enter admission findings to calculate the published 0–9 point CardShock risk score.

0Score / 9
1 point if age is strictly greater than 75 years.
1 point if LVEF is strictly below 40%.
<2 = 0 points; 2–4 inclusive = 1 point; >4 = 2 points.
>60 = 0 points; 30–60 inclusive = 1 point; <30 = 2 points. Original score specifies eGFR by CKD-EPI.
Confusion or altered mental status at presentation?
Previous myocardial infarction (MI) or coronary artery bypass grafting (CABG)?
Acute coronary syndrome (ACS) as the cause of cardiogenic shock?

About the CardShock risk score

The CardShock score was developed to stratify short-term, including in-hospital, mortality risk in adults with cardiogenic shock from ACS and non-ACS causes. It uses seven admission variables and has a maximum of 9 points.

Variables and point allocation

VariableCriterionPoints
Age>75 years1
ConfusionPresent at admission1
Medical historyPrevious MI or CABG1
AetiologyACS-related shock1
LVEF<40%1
Blood lactate<2 / 2–4 / >4 mmol/L0 / 1 / 2
eGFR (CKD-EPI)>60 / 30–60 / <30 mL/min/1.73 m²0 / 1 / 2

Risk groups in the derivation cohort

ScoreRisk groupObserved in-hospital mortality
0–3Low8.7%
4–5Intermediate36%
6–9High77%

These mortality percentages describe groups in the original study and should not be interpreted as guaranteed outcomes for an individual patient.

References

Harjola V-P, Lassus J, Sionis A, et al.Clinical picture and risk prediction of short-term mortality in cardiogenic shock. European Journal of Heart Failure. 2015;17(5):501–509. Original CardShock derivation study. doi:10.1002/ejhf.260; PMID: 25820680.
Hongisto M, et al.Mortality risk prediction in elderly patients with cardiogenic shock: results from the CardShock study. ESC Heart Failure. 2021;8(2):1398–1407. Describes score variables and risk groups. doi:10.1002/ehf2.13224; Full text.
External validation in real-world cardiogenic shock patients.External validation and comparison of the CardShock and IABP-SHOCK II risk scores in real-world cardiogenic shock patients. International Journal of Cardiology. 2020. Notes that discrimination may vary by aetiology and clinical cohort. PubMed record.